# AKIP1

## Overview
AKIP1, or A-kinase interacting protein 1, is a gene that encodes a protein of the same name, which functions as a key regulator in various cellular processes. The AKIP1 protein is primarily known for its role as a molecular scaffold, facilitating interactions with protein kinase A (PKA) and the p65 subunit of NF-κB, thereby influencing NF-κB-dependent gene expression and cellular signaling pathways (Gao2008AKIP1; King2011The). It is involved in cardiac and mitochondrial functions, promoting physiological cardiac hypertrophy and enhancing mitochondrial respiration efficiency (Nijholt2023A; Yu2013AKIP1). Additionally, AKIP1 is implicated in cancer progression, where its overexpression is associated with poor prognosis in various cancers, including hepatocellular carcinoma and colorectal cancer (Jiang2018Upregulation; Cui2019AKIP1). The protein's involvement in critical signaling pathways and disease states highlights its potential as a target for therapeutic intervention.

## Function
AKIP1 (A-kinase interacting protein 1) is involved in several molecular processes within healthy human cells, primarily influencing cardiac and mitochondrial functions. In cardiomyocytes, AKIP1 promotes physiological cardiac hypertrophy, a beneficial form of cardiac growth, by enhancing cardiomyocyte elongation and remodeling. This process involves the reduction of RSK3 mRNA expression and the activation of the PP2Ac-SRF signalosome, which contributes to exercise-induced cardiac hypertrophy (Nijholt2023A). AKIP1 also plays a role in mitochondrial function by increasing the efficiency of mitochondrial respiration and ATP production without inducing mitochondrial biogenesis. It enhances the oxygen consumption rate and reduces superoxide formation, indicating improved electron transport chain efficiency and reduced oxidative stress (Yu2013AKIP1).

AKIP1 is active in the nucleus and cytoplasm, where it interacts with protein kinase A (PKA) and the p65 subunit of NF-κB, promoting NF-κB-dependent gene expression. This interaction facilitates the nuclear retention and phosphorylation of p65, enhancing transcriptional activity in response to stimuli like TNFα (Gao2008AKIP1). These activities suggest that AKIP1 is a key regulator in cellular signaling pathways, contributing to both cardiac and immune functions.

## Clinical Significance
AKIP1 (A-kinase interacting protein 1) is implicated in the progression and poor prognosis of several cancers due to its overexpression and altered interactions. In hepatocellular carcinoma (HCC), AKIP1 is highly expressed and associated with early recurrence and poor patient outcomes. It promotes β-catenin nuclear retention, affecting the Wnt/β-catenin signaling pathway, and enhances NF-κB transcriptional activity, contributing to cancer progression and metastasis (Cui2019AKIP1). In colorectal cancer (CRC), AKIP1 expression correlates with advanced TNM stages and lymph node metastasis, leading to poorer overall survival rates (Jiang2018Upregulation).

In cervical cancer, AKIP1 promotes epithelial-mesenchymal transition (EMT) and metastasis through the PI3K/Akt/IKKβ pathway, activating NF-κB signaling (Zhang2020A‐kinase‐interacting). AKIP1 is also overexpressed in non-small cell lung cancer (NSCLC), where it is linked to worse disease-free and overall survival, serving as an independent predictive factor for poor prognosis (Liu2019AKIP1). In gastric cancer, AKIP1 facilitates growth and metastasis by inducing EMT through the transcription factor Slug (Chen2019A‐kinase‐interacting). These findings suggest that AKIP1 plays a significant role in cancer progression and could be a potential target for therapeutic intervention.

## Interactions
AKIP1 (A-kinase interacting protein 1) is involved in several protein interactions that play significant roles in cellular processes. It interacts with Rac1, a protein associated with cancer progression, in clear cell renal cell carcinoma (ccRCC) cells. This interaction influences the ERK/c-Myc signaling pathway, which is crucial for cancer cell proliferation and metastasis (Zhang2022A‑kinase).

AKIP1 also interacts with the catalytic subunit of protein kinase A (PKAc) and the p65 subunit of NF-κB. It acts as a molecular scaffold, facilitating the nuclear translocation of PKAc and enhancing NF-κB signaling by promoting the phosphorylation of p65 at Ser-276. This interaction is crucial for NF-κB-dependent transcription, particularly in the context of anti-apoptotic gene expression (Gao2010Akinaseinteracting; King2011The; Gao2008AKIP1).

In cardiac cells, AKIP1 is localized in mitochondria, where it interacts with PKAc and apoptosis-inducing factor (AIF), playing a role in mitochondrial adaptation to stress and protection against ischemia/reperfusion injury (Sastri2013A). These interactions highlight AKIP1's multifaceted role in regulating cellular signaling pathways and stress responses.


## References


[1. (Gao2008AKIP1) Nan Gao, Kaori Asamitsu, Yurina Hibi, Takaharu Ueno, and Takashi Okamoto. Akip1 enhances nf-κb-dependent gene expression by promoting the nuclear retention and phosphorylation of p65. Journal of Biological Chemistry, 283(12):7834–7843, March 2008. URL: http://dx.doi.org/10.1074/jbc.M710285200, doi:10.1074/jbc.m710285200. This article has 94 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.M710285200)

[2. (Jiang2018Upregulation) Weifang Jiang, Weiji Yang, Li Yuan, and Fanlong Liu. Upregulation of akip1 contributes to metastasis and progression and predicts poor prognosis of patients with colorectal cancer. OncoTargets and Therapy, Volume 11:6795–6801, October 2018. URL: http://dx.doi.org/10.2147/OTT.S151952, doi:10.2147/ott.s151952. This article has 21 citations and is from a peer-reviewed journal.](https://doi.org/10.2147/OTT.S151952)

[3. (Cui2019AKIP1) Yanmei Cui, Xianqiu Wu, Chuyong Lin, Xin Zhang, Liping Ye, Liangliang Ren, Min Chen, Meisongzhu Yang, Yue Li, Mengfeng Li, Jun Li, Jian Guan, and Libing Song. Akip1 promotes early recurrence of hepatocellular carcinoma through activating the wnt/β-catenin/cbp signaling pathway. Oncogene, 38(27):5516–5529, April 2019. URL: http://dx.doi.org/10.1038/s41388-019-0807-5, doi:10.1038/s41388-019-0807-5. This article has 37 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/s41388-019-0807-5)

[4. (Gao2010Akinaseinteracting) Nan Gao, Yurina Hibi, Marni Cueno, Kaori Asamitsu, and Takashi Okamoto. A-kinase-interacting protein 1 (akip1) acts as a molecular determinant of pka in nf-κb signaling. Journal of Biological Chemistry, 285(36):28097–28104, September 2010. URL: http://dx.doi.org/10.1074/jbc.m110.116566, doi:10.1074/jbc.m110.116566. This article has 64 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.m110.116566)

[5. (Sastri2013A) Mira Sastri, Kristofer J. Haushalter, Mathivadhani Panneerselvam, Philip Chang, Heidi Fridolfsson, J. Cameron Finley, Daniel Ng, Jan M. Schilling, Atsushi Miyanohara, Michele E. Day, Hiro Hakozaki, Susanna Petrosyan, Antonius Koller, Charles C. King, Manjula Darshi, Donald K. Blumenthal, Sameh Saad Ali, David M. Roth, Hemal H. Patel, and Susan S. Taylor. A kinase interacting protein (akip1) is a key regulator of cardiac stress. Proceedings of the National Academy of Sciences, January 2013. URL: http://dx.doi.org/10.1073/pnas.1221670110, doi:10.1073/pnas.1221670110. This article has 30 citations.](https://doi.org/10.1073/pnas.1221670110)

[6. (Liu2019AKIP1) Yingchao Liu, Jia Tian, Dongrui Qin, Jiaqi Liu, and Yaozeng Xie. Akip1 expression in tumor tissue as a new biomarker for disease monitoring and prognosis in non‐small cell lung cancer: results of a retrospective study. Journal of Clinical Laboratory Analysis, November 2019. URL: http://dx.doi.org/10.1002/jcla.23128, doi:10.1002/jcla.23128. This article has 6 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/jcla.23128)

[7. (Zhang2020A‐kinase‐interacting) Xiujuan Zhang, Shuxian Liu, and Yongqing Zhu. A‐kinase‐interacting protein 1 promotes <scp>emt</scp> and metastasis via <scp>pi3k</scp>/akt/<scp>ikkβ</scp> pathway in cervical cancer. Cell Biochemistry and Function, 38(6):782–791, May 2020. URL: http://dx.doi.org/10.1002/cbf.3547, doi:10.1002/cbf.3547. This article has 13 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/cbf.3547)

[8. (Yu2013AKIP1) Hongjuan Yu, Wardit Tigchelaar, Debby P. Y. Koonen, Hemal H. Patel, Rudolf A. de Boer, Wiek H. van Gilst, B. Daan Westenbrink, and Herman H. W. Silljé. Akip1 expression modulates mitochondrial function in rat neonatal cardiomyocytes. PLoS ONE, 8(11):e80815, November 2013. URL: http://dx.doi.org/10.1371/journal.pone.0080815, doi:10.1371/journal.pone.0080815. This article has 16 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0080815)

[9. (Chen2019A‐kinase‐interacting) Dehu Chen, Gan Cao, and Qinghong Liu. A‐kinase‐interacting protein 1 facilitates growth and metastasis of gastric cancer cells via slug‐induced epithelial‐mesenchymal transition. Journal of Cellular and Molecular Medicine, 23(6):4434–4442, April 2019. URL: http://dx.doi.org/10.1111/jcmm.14339, doi:10.1111/jcmm.14339. This article has 21 citations and is from a peer-reviewed journal.](https://doi.org/10.1111/jcmm.14339)

[10. (Nijholt2023A) Kirsten T. Nijholt, Pablo I. Sánchez-Aguilera, Harmen G. Booij, Silke U. Oberdorf-Maass, Martin M. Dokter, Anouk H. G. Wolters, Ben N. G. Giepmans, Wiek H. van Gilst, Joan H. Brown, Rudolf A. de Boer, Herman H. W. Silljé, and B. Daan Westenbrink. A kinase interacting protein 1 (akip1) promotes cardiomyocyte elongation and physiological cardiac remodelling. Scientific Reports, March 2023. URL: http://dx.doi.org/10.1038/s41598-023-30514-1, doi:10.1038/s41598-023-30514-1. This article has 3 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41598-023-30514-1)

[11. (King2011The) Charles C. King, Mira Sastri, Philip Chang, Juniper Pennypacker, and Susan S. Taylor. The rate of nf-κb nuclear translocation is regulated by pka and a kinase interacting protein 1. PLoS ONE, 6(4):e18713, April 2011. URL: http://dx.doi.org/10.1371/journal.pone.0018713, doi:10.1371/journal.pone.0018713. This article has 43 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0018713)

[12. (Zhang2022A‑kinase) Yu Zhang, Haijian Zhang, Zhixing Han, Xudong Wang, Xuyu Li, Pengfei Yuan, Shiqi Ji, and Qingjun Liu. A‑kinase interacting protein 1 regulates the cell proliferation, invasion, migration and angiogenesis of clear cell renal cell carcinoma cells and affects the erk/c‑myc signaling pathway by binding to rac1. Experimental and Therapeutic Medicine, July 2022. URL: http://dx.doi.org/10.3892/etm.2022.11489, doi:10.3892/etm.2022.11489. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.3892/etm.2022.11489)